Sandostatin i Sandostatin LAR pri metabolicheskikh, neyroendokrinnykh i onkologicheskikh zabolevaniyakh

Octreotide is a synthetic analog of hypothalamic hormone somatostatin. This neuropeptide is widely distributed in humans and animals in central nervous system and periphery, which defines its potential regulatory functions. In 1987 the first registration was received for octreotide preparation, Sand...

Full description

Bibliographic Details
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2011-03-01
Series:	Ожирение и метаболизм
Subjects:	соматостатин октреотид Сандостатин Сандостатин ЛАР акромегалия нейроэндокрин- ные опухоли ожирение
Online Access:	https://endojournals.ru/index.php/omet/article/view/5188

id	doaj-a46cfdc3bdaa44fcaa66b032842341ab
record_format	Article
spelling	doaj-a46cfdc3bdaa44fcaa66b032842341ab2021-10-02T15:44:24ZengEndocrinology Research CentreОжирение и метаболизм2071-87132306-55242011-03-0181263010.14341/2071-8713-51885146Sandostatin i Sandostatin LAR pri metabolicheskikh, neyroendokrinnykh i onkologicheskikh zabolevaniyakhOctreotide is a synthetic analog of hypothalamic hormone somatostatin. This neuropeptide is widely distributed in humans and animals in central nervous system and periphery, which defines its potential regulatory functions. In 1987 the first registration was received for octreotide preparation, Sandostatin, for treatment of acromegaly and carcinoid tumors. In 1997 a long lasting form of octreotide appeared - Sandostatin LAR. At the present time both preparations have found their use in multiple areas of medicine for treatment of different metabolic, neuroendocrine and oncologic diseases.https://endojournals.ru/index.php/omet/article/view/5188соматостатиноктреотидСандостатинСандостатин ЛАРакромегалиянейроэндокрин- ные опухолиожирение
collection	DOAJ
language	English
format	Article
sources	DOAJ
title	Sandostatin i Sandostatin LAR pri metabolicheskikh, neyroendokrinnykh i onkologicheskikh zabolevaniyakh
spellingShingle	Sandostatin i Sandostatin LAR pri metabolicheskikh, neyroendokrinnykh i onkologicheskikh zabolevaniyakh Ожирение и метаболизм соматостатин октреотид Сандостатин Сандостатин ЛАР акромегалия нейроэндокрин- ные опухоли ожирение
title_short	Sandostatin i Sandostatin LAR pri metabolicheskikh, neyroendokrinnykh i onkologicheskikh zabolevaniyakh
title_full	Sandostatin i Sandostatin LAR pri metabolicheskikh, neyroendokrinnykh i onkologicheskikh zabolevaniyakh
title_fullStr	Sandostatin i Sandostatin LAR pri metabolicheskikh, neyroendokrinnykh i onkologicheskikh zabolevaniyakh
title_full_unstemmed	Sandostatin i Sandostatin LAR pri metabolicheskikh, neyroendokrinnykh i onkologicheskikh zabolevaniyakh
title_sort	sandostatin i sandostatin lar pri metabolicheskikh, neyroendokrinnykh i onkologicheskikh zabolevaniyakh
publisher	Endocrinology Research Centre
series	Ожирение и метаболизм
issn	2071-8713 2306-5524
publishDate	2011-03-01
description	Octreotide is a synthetic analog of hypothalamic hormone somatostatin. This neuropeptide is widely distributed in humans and animals in central nervous system and periphery, which defines its potential regulatory functions. In 1987 the first registration was received for octreotide preparation, Sandostatin, for treatment of acromegaly and carcinoid tumors. In 1997 a long lasting form of octreotide appeared - Sandostatin LAR. At the present time both preparations have found their use in multiple areas of medicine for treatment of different metabolic, neuroendocrine and oncologic diseases.
topic	соматостатин октреотид Сандостатин Сандостатин ЛАР акромегалия нейроэндокрин- ные опухоли ожирение
url	https://endojournals.ru/index.php/omet/article/view/5188
_version_	1716853355509186560

Sandostatin i Sandostatin LAR pri metabolicheskikh, neyroendokrinnykh i onkologicheskikh zabolevaniyakh

Similar Items